Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-JP-06
Country
JP
Application Type
National Stage
Patent Status
Issued
Patent Number
Publication Number
2017-501220
Application Number
2016-558546
IC
NCI
Date Filed
Date Issued
Patent PDF